Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -17.51% | 16.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.51% | 16.40% | |||
| Cost of Revenue | 3.10% | -6.97% | |||
| Gross Profit | -27.15% | 31.87% | |||
| SG&A Expenses | 5.69% | -8.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.83% | -7.83% | |||
| Operating Income | -2,058.82% | 95.43% | |||
| Income Before Tax | -154.37% | 56.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -154.37% | 56.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -144.53% | 56.47% | |||
| EBIT | -2,058.82% | 95.43% | |||
| EBITDA | -997.99% | 111.12% | |||
| EPS Basic | -141.38% | 57.28% | |||
| Normalized Basic EPS | -137.04% | 57.28% | |||
| EPS Diluted | -141.38% | 57.28% | |||
| Normalized Diluted EPS | -137.04% | 57.28% | |||
| Average Basic Shares Outstanding | 0.85% | 1.89% | |||
| Average Diluted Shares Outstanding | 0.85% | 1.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
